UK launch for Vagirux
admin 7th December 2020 Uncategorised 0The drug is administered intravaginally as a local oestrogen therapy for treatment of vaginal atrophy due to oestrogen deficiency. More: UK launch for Vagirux Source: News
read more
The drug is administered intravaginally as a local oestrogen therapy for treatment of vaginal atrophy due to oestrogen deficiency. More: UK launch for Vagirux Source: News
read moreExtension application is based on results from Janssen’s Route 6 study More: Janssen seeks EU approval for twice-yearly schizophrenia treatment Source: News
read moreASH: AstraZeneca’s Calquence, BeiGene’s Brukinsa turn heads with new data, putting Imbruvica on notice chelfand Sun, 12/06/2020 – 15:06 More: ASH: AstraZeneca's Calquence, BeiGene's Brukinsa turn heads with new data, putting Imbruvica on notice Source: fierce
read moreASH: Novartis makes its Kymriah case in follicular lymphoma, but another Gilead showdown awaits chelfand Sat, 12/05/2020 – 15:10 More: ASH: Novartis makes its Kymriah case in follicular lymphoma, but another Gilead showdown awaits Source: fierce
read moreASH: AbbVie, Roche’s fixed-duration Venclexta combos gain steam in CLL chelfand Sat, 12/05/2020 – 12:30 More: ASH: AbbVie, Roche's fixed-duration Venclexta combos gain steam in CLL Source: fierce
read moreASH: Incyte, Novartis eye Jakafi approval after chronic graft vs. host win chelfand Sat, 12/05/2020 – 02:25 More: ASH: Incyte, Novartis eye Jakafi approval after chronic graft vs. host win Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals